Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 29;8(4):102500.
doi: 10.1016/j.rpth.2024.102500. eCollection 2024 May.

Starving in the land of plenty: the challenge of studying menstruation in anticoagulated patients

Bethany T Samuelson Bannow  1   2
Affiliations

Starving in the land of plenty: the challenge of studying menstruation in anticoagulated patients

Bethany T Samuelson Bannow. Res Pract Thromb Haemost. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Management strategies for abnormal uterine bleeding, including modifications for patients requiring anticoagulation and therapies relevant only to those on anticoagulation. AC, anticoagulation; CHC, combined hormonal contraceptive; DMPA, depot medroxyprogesterone acetate; IUD, intrauterine device. ∗Evidence on the duration of increased venous thromboembolism risk following DMPA administration is unknown; therefore, the optimal timing of discontinuation prior to stopping AC is unclear. Additionally, DMPA is administered intramuscularly and therefore carries a theoretical risk of hematoma formation.
See this image and copyright information in PMC

References

    1. Patel J.P., Nzelu O., Roberts L.N., Johns J., Ross J., Arya R. How do anticoagulants impact menstrual bleeding and quality of life? - the PERIOD study. Res Pract Thromb Haemost. 2023;7 doi: 10.1016/j.rpth.2023.100072. - DOI - PMC - PubMed
    1. Hamulyák E.N., Wiegers H.M.G., Hutten B.A., de Lange M.E., Timmermans A., Westerweel P.E., et al. Heavy menstrual bleeding on direct factor Xa inhibitors - the MEDEA randomized clinical trial. Res Pract Thromb Haemost. 2024;8 doi: 10.1016/j.rpth.2024.102448. - DOI - PMC - PubMed
    1. Boonyawat K., Lensing A.W.A., Prins M.H., Beyer-Westendorf J., Prandoni P., Martinelli I., et al. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: comparison of high- and low-dose rivaroxaban with aspirin. Res Pract Thromb Haemost. 2021;5:308–313. - PMC - PubMed
    1. Bryk A.H., Pirog M., Plens K., Undas A. Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism. Vascul Pharmacol. 2016;87:242–247. - PubMed
    1. Martinelli I., Lensing A.W., Middeldorp S., Levi M., Beyer-Westendorf J., van Bellen B., et al. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood. 2016;127:1417–1425. - PMC - PubMed

LinkOut - more resources